CXL Update Emphasizes Security
By Gary Hilson, EETimes (January 3, 2025)
The latest point release to the Compute Express Link specification aims to optimize monitoring and management and enhance functionality for operating systems and applications—all while extending security.
The updates reflect the rapid growth of AI in the data center, even though the coherent connectivity protocol was conceived before the AI boom took off, Anil Godbole, CXL Consortium marketing working group co-chair, said in a briefing with EE Times.
The latest CXL update, CXL 3.2, adds several monitoring and management capabilities, including a CXL hot-page monitoring unit (CHMU) for memory tiering, common event record, compatibility with PCIe management message pass through (MMPT) and CXL online firmware (FW) activation.
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |
Related News
- CXL Consortium Announces Compute Express Link 3.2 Specification Release
- USB 3.0 Promoter Group Announces USB 3.2 Update
- RaiderChip brings Meta Llama 3.2 LLM HW acceleration to low cost FPGAs
- Paul Williamson on Edge AI, Llama 3.2 on Arm
- Production Proven USB 3.2 Gen1/Gen2 IP Cores to ensure a seamless throughput for Next-Gen SoCs available for Immediate licensing
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- SiFive and Kinara Partner to Offer Bare Metal Access to RISC-V Vector Processors
- Imagination Announces E-Series: A New Era of On-Device AI and Graphics
- Siemens to accelerate customer time to market with advanced silicon IP through new Alphawave Semi partnership
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design